Literature DB >> 19205965

A prototype approach toward antipsychotic medication adherence in schizophrenia.

Oliver Freudenreich1, Constantin Tranulis.   

Abstract

Antipsychotic nonadherence in psychotic disorders is a vexing clinical problem. While many risk factors are associated with nonadherence, a risk factor model per se is a poor guide for clinical decisions. We propose a pragmatic clinical prototype approach that incorporates two variables, medication drug attitude and worldview (with regard to mental illness and psychiatric treatment), to create five patient prototypes of adherence: patients with good adherence for the right reasons ("True Believer"), with good adherence for the wrong reasons ("Clinic Trouper"), with reluctant and tenuous adherence ("Reluctant Recruit"), with passive adherence ("The Coffee Guy"), and with unwillingness to take medications ("Constitutional Combatant"). Actual patients can be compared and assigned to one of the prototypes, with the group membership predicting level and character of adherence, and suggesting specific interventions. In this scheme, drug attitude and worldview are key variables for adherence; both can be ascertained during the clinical interview and quantified with rating scales.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19205965     DOI: 10.1080/10673220902724565

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  6 in total

1.  Treatment selection using prototyping in latent-space with application to depression treatment.

Authors:  Akiva Kleinerman; Ariel Rosenfeld; David Benrimoh; Robert Fratila; Caitrin Armstrong; Joseph Mehltretter; Eliyahu Shneider; Amit Yaniv-Rosenfeld; Jordan Karp; Charles F Reynolds; Gustavo Turecki; Adam Kapelner
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

2.  Insight in schizophrenia and its association with executive functions.

Authors:  Sonali Choudhury; C R J Khess; Ranjan Bhattacharyya; Debasish Sanyal
Journal:  Indian J Psychol Med       Date:  2009-07

3.  [Risk factors for treatment adherence in patients with schizophrenia: case-control study].

Authors:  Chadya Aarab; Fatima Elghazouani; Rachid Aalouane; Ismail Rammouz
Journal:  Pan Afr Med J       Date:  2015-03-20

4.  A randomized controlled trial with a Canadian electronic pill dispenser used to measure and improve medication adherence in patients with schizophrenia.

Authors:  Emmanuel Stip; Philippe D Vincent; Juliette Sablier; Catherine Guevremont; Simon Zhornitsky; Constantin Tranulis
Journal:  Front Pharmacol       Date:  2013-08-09       Impact factor: 5.810

5.  From trust to skepticism: An in-depth analysis across age groups of adults with sickle cell disease on their perspectives regarding hydroxyurea.

Authors:  Cynthia B Sinha; Nitya Bakshi; Diana Ross; Lakshmanan Krishnamurti
Journal:  PLoS One       Date:  2018-06-27       Impact factor: 3.240

6.  Attitudes toward psychotropic medications among patients with chronic psychiatric disorders and their family caregivers.

Authors:  Sandeep Grover; Subho Chakrabarti; Aarti Sharma; Shikha Tyagi
Journal:  J Neurosci Rural Pract       Date:  2014-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.